1. Home
  2. SPRC vs SEEL Comparison

SPRC vs SEEL Comparison

Compare SPRC & SEEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • SEEL
  • Stock Information
  • Founded
  • SPRC 2004
  • SEEL 2016
  • Country
  • SPRC Israel
  • SEEL United States
  • Employees
  • SPRC N/A
  • SEEL N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • SEEL Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPRC Health Care
  • SEEL Health Care
  • Exchange
  • SPRC Nasdaq
  • SEEL Nasdaq
  • Market Cap
  • SPRC 1.2M
  • SEEL 1.4M
  • IPO Year
  • SPRC N/A
  • SEEL N/A
  • Fundamental
  • Price
  • SPRC $0.31
  • SEEL $0.19
  • Analyst Decision
  • SPRC
  • SEEL Hold
  • Analyst Count
  • SPRC 0
  • SEEL 3
  • Target Price
  • SPRC N/A
  • SEEL $240.00
  • AVG Volume (30 Days)
  • SPRC 2.8M
  • SEEL 4.1M
  • Earning Date
  • SPRC 09-27-2024
  • SEEL 08-14-2024
  • Dividend Yield
  • SPRC N/A
  • SEEL N/A
  • EPS Growth
  • SPRC N/A
  • SEEL N/A
  • EPS
  • SPRC N/A
  • SEEL 2.94
  • Revenue
  • SPRC $2,879,000.00
  • SEEL $2,013,999.00
  • Revenue This Year
  • SPRC N/A
  • SEEL N/A
  • Revenue Next Year
  • SPRC N/A
  • SEEL $9,366.67
  • P/E Ratio
  • SPRC N/A
  • SEEL $0.07
  • Revenue Growth
  • SPRC 113.73
  • SEEL 76.05
  • 52 Week Low
  • SPRC $0.28
  • SEEL $0.18
  • 52 Week High
  • SPRC $14.22
  • SEEL $242.40
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 38.57
  • SEEL 33.30
  • Support Level
  • SPRC $0.28
  • SEEL $0.18
  • Resistance Level
  • SPRC $0.32
  • SEEL $0.31
  • Average True Range (ATR)
  • SPRC 0.03
  • SEEL 0.03
  • MACD
  • SPRC 0.00
  • SEEL 0.00
  • Stochastic Oscillator
  • SPRC 20.67
  • SEEL 20.38

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About SEEL Seelos Therapeutics Inc.

Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders. Its product pipeline includes SLS-002, SLS-005, SLS-004, SLS-007, and SLS-009.

Share on Social Networks: